Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?

Eur Heart J. 2012 Nov;33(22):2764-5. doi: 10.1093/eurheartj/ehs277. Epub 2012 Aug 27.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benzazepines / therapeutic use*
  • Cardiotonic Agents / therapeutic use*
  • Female
  • Heart Failure, Systolic / drug therapy*
  • Humans
  • Ivabradine
  • Male

Substances

  • Benzazepines
  • Cardiotonic Agents
  • Ivabradine